Affirm downgraded to Underweight from Equal Weight at Morgan Stanley

Morgan Stanley downgraded Affirm to Underweight from Equal Weight with a price target of $20, up from $15. Risk-reward appears skewed to the downside at current levels even with pending strength through a seasonally strong holiday period, and valuation seems difficult to justify across all metrics, the analyst tells investors in a research note.